Book Your Consultation Safety & Candidacy Well-Researched Regenerative Peptide GHK-Cu is a naturally occurring peptide with extensive research supporting its safety and efficacy for tissue repair and regeneration
The LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) studies showed no significant increase in pancreatitis rates compared to placebo
We will conclude by listing research priorities for the future
These factors support continued research interest despite the disappointing oral efficacy results
Key Areas of Research: Structural: Collagen, matrix, tendon Vascular: Angiogenesis, nitric oxide, repair Dermatological: Wound closure, vessel growth, cells Systemic: Protection, viability, recovery Together, these findings suggest broad experimental utility for BPC-157 across multiple biological pathways